has been cited by the following article(s):
|
[1]
|
Advancing posaconazole quantification analysis with a new reverse-phase HPLC method in its bulk and marketed dosage form
F1000Research,
2023
DOI:10.12688/f1000research.132841.2
|
|
|
|
|
[2]
|
Advancing posaconazole quantification analysis with a new reverse-phase HPLC method in its bulk and marketed dosage form
F1000Research,
2023
DOI:10.12688/f1000research.132841.1
|
|
|
|
|
[3]
|
Development and Validation of a LC–MS/MS Method for the Profiling of Impurities Formed during Stress Study of Antifungal Agent—Efinaconazole
Journal of Chromatographic Science,
2022
DOI:10.1093/chromsci/bmab079
|
|
|
|
|
[4]
|
Identification, synthesis, characterization, and a quality control strategy for high-risk chiral impurities in the antifungal drug substance posaconazole
Tetrahedron,
2022
DOI:10.1016/j.tet.2022.133098
|
|
|
|
|
[5]
|
Identification, synthesis, characterization, and a quality control strategy for high-risk chiral impurities in the antifungal drug substance posaconazole
Tetrahedron,
2022
DOI:10.1016/j.tet.2022.133098
|
|
|
|
|
[6]
|
Stability study and oxidative degradation kinetics of posaconazole
Microchemical Journal,
2019
DOI:10.1016/j.microc.2019.104181
|
|
|
|